Marc N. Hirt

Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf

Affiliated withUniversity Medical Center Hamburg-Eppendorf DZHK (German Centre for Cardiovascular Research)

Research Area

Biography

Marc N. Hirt has not added Biography.
If you are Marc N. Hirt and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2020

Other Publications

Article	Year
Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PloS one\| PubMed ID: 22028871	2011
Increased afterload induces pathological cardiac hypertrophy: a new in vitro model. Basic research in cardiology\| PubMed ID: 23099820	2012
Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice. Journal of molecular and cellular cardiology\| PubMed ID: 23896226	2013
Cardiac tissue engineering: state of the art. Circulation research\| PubMed ID: 24436431	2014
Automated analysis of contractile force and Ca2+ transients in engineered heart tissue. American journal of physiology. Heart and circulatory physiology\| PubMed ID: 24585781	2014
Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation. Journal of molecular and cellular cardiology\| PubMed ID: 24852842	2014
Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology. Journal of molecular and cellular cardiology\| PubMed ID: 25633833	2015
General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study. Clinical research in cardiology : official journal of the German Cardiac Society\| PubMed ID: 26552905	2016
DNA methylation in an engineered heart tissue model of cardiac hypertrophy: common signatures and effects of DNA methylation inhibitors. Basic research in cardiology\| PubMed ID: 26680771	2016
Spontaneous Formation of Extensive Vessel-Like Structures in Murine Engineered Heart Tissue. Tissue engineering. Part A\| PubMed ID: 26763667	2016
Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue. PloS one\| PubMed ID: 26840448	2016
Human Engineered Heart Tissue: Analysis of Contractile Force. Stem cell reports\| PubMed ID: 27211213	2016
Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. Circulation\| PubMed ID: 27559042	2016
Human iPSC-derived cardiomyocytes cultured in 3D engineered heart tissue show physiological upstroke velocity and sodium current density. Scientific reports\| PubMed ID: 28710467	2017
Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats. Journal of molecular and cellular cardiology\| PubMed ID: 29792884	2018
S100A4 as a Target of the E3-Ligase Asb2β and Its Effect on Engineered Heart Tissue. Frontiers in physiology\| PubMed ID: 30283351	2018
Toward Second-Generation Cardiomyogenic and Anti-cardiofibrotic 1,4-Dihydropyridine-Class TGFβ Inhibitors. ChemMedChem\| PubMed ID: 30768867	2019
Blockade of miR-140-3p prevents functional deterioration in afterload-enhanced engineered heart tissue. Scientific reports\| PubMed ID: 31391475	2019
Long Noncoding RNA-Enriched Vesicles Secreted by Hypoxic Cardiomyocytes Drive Cardiac Fibrosis. Molecular therapy. Nucleic acids\| PubMed ID: 31634682	2019
A magnetics-based approach for fine-tuning afterload in engineered heart tissues. ACS biomaterials science & engineering\| PubMed ID: 31637285	2019
Phosphomimetic cardiac myosin-binding protein C partially rescues a cardiomyopathy phenotype in murine engineered heart tissue. Scientific reports\| PubMed ID: 31796859	2019
Aging-regulated anti-apoptotic long non-coding RNA Sarrah augments recovery from acute myocardial infarction. Nature communications\| PubMed ID: 32341350	2020